Evidence map›Paper›PMID 28710472›Full record

ArticleScientific reports2017

Novel data analysis method for multicolour flow cytometry links variability of multiple markers on single cells to a clinical phenotype.

Gerjen H Tinnevelt, Marietta Kokla, Bart Hilvering, Selma van Staveren, Rita Folcarelli, Luzheng Xue, Andries C Bloem, Leo Koenderman, Lutgarde M C Buydens, Jeroen J Jansen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Analytical Appraisal of Hematogones in B-ALL MRD Assessment Using Multidimensional Dot-Plots by Multiparametric Flow Cytometry: A Critical Review and Update.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2024
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Gerjen H TinneveltRadboud University, Institute for Molecules and Materials, (Analytical Chemistry), P.O. Box 9010, 6500 GL, Nijmegen, The Netherlands. gtinnevelt@science.ru.nl.ORCID 0000-0003-0758-4128
Marietta KoklaRadboud University, Institute for Molecules and Materials, (Analytical Chemistry), P.O. Box 9010, 6500 GL, Nijmegen, The Netherlands.ORCID 0000-0002-8152-2024
Bart HilveringDepartment of Respiratory Medicine and laboratory of translational immunology (LTI), University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.
Selma van StaverenTI-COAST, Science Park 904, 1098 XH, Amsterdam, The Netherlands.
Rita FolcarelliRadboud University, Institute for Molecules and Materials, (Analytical Chemistry), P.O. Box 9010, 6500 GL, Nijmegen, The Netherlands.
Luzheng XueRespiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, United Kingdom.
Andries C BloemDepartment of Immunology, University Medical Center, University of Utrecht, 3508GA, Utrecht, The Netherlands.
Leo KoendermanDepartment of Respiratory Medicine and laboratory of translational immunology (LTI), University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.
Lutgarde M C BuydensRadboud University, Institute for Molecules and Materials, (Analytical Chemistry), P.O. Box 9010, 6500 GL, Nijmegen, The Netherlands.
Jeroen J JansenRadboud University, Institute for Molecules and Materials, (Analytical Chemistry), P.O. Box 9010, 6500 GL, Nijmegen, The Netherlands.
Radboud University Nijmegen · NLHeidelberg University · DECentrum Wiskunde & Informatica · NLUniversity of Oxford · GBUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multicolour Flow Cytometry (MFC) produces multidimensional analytical data on the quantitative expression of multiple markers on single cells. This data contains invaluable biomedical information on (1) the marker expressions per cell, (2) the variation in such expression across cells, (3) the variability of cell marker expression across samples that (4) may vary systematically between cells collected from donors and patients. Current conventional and even advanced data analysis methods for MFC data explore only a subset of these levels. The Discriminant Analysis of MultiAspect CYtometry (DAMACY) we present here provides a comprehensive view on health and disease responses by integrating all four levels. We validate DAMACY by using three distinct datasets: in vivo response of neutrophils evoked by systemic endotoxin challenge, the clonal response of leukocytes in bone marrow of acute myeloid leukaemia (AML) patients, and the complex immune response in blood of asthmatics. DAMACY provided good accuracy 91-100% in the discrimination between health and disease, on par with literature values. Additionally, the method provides figures that give insight into the marker expression and cell variability for more in-depth interpretation, that can benefit both physicians and biomedical researchers to better diagnose and monitor diseases that are reflected by changes in blood leukocytes.

Indexed as

Data AnalysisSingle-Cell AnalysisAdultAgedAsthmaBiomarkersColorDiscriminant AnalysisFlow CytometryHumansLeukemia, Myeloid, AcuteLipopolysaccharidesMiddle AgedModels, BiologicalPhenotypeYoung AdultBiomarkersLipopolysaccharides

Identifiers

PMID28710472
PMCPMC5511252
OpenAlexW2734733692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.